| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/04/2014 | US8664229 Heterocyclic compounds as pesticides |
| 03/04/2014 | US8664226 Compound having 3-heteroarylpyrimidin-4-(3H)-one structure and pharmaceutical preparation containing same |
| 03/04/2014 | US8664223 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 03/04/2014 | US8664217 Benzodiazepine compound and pharmaceutical composition |
| 02/27/2014 | WO2014031971A1 Herbicidal pyridazinones |
| 02/27/2014 | WO2014031784A1 Compounds for the treatment of paramoxyvirus viral infections |
| 02/27/2014 | WO2014031584A1 Haptens of aripiprazole and their use in immunoassays |
| 02/27/2014 | WO2014031170A1 Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
| 02/27/2014 | WO2014030743A1 Heterocycic compound |
| 02/27/2014 | WO2014030709A1 Compound suitable for detection of mitochondrial complex-1 |
| 02/27/2014 | WO2014030170A1 Acrylamide compounds as histamine h3 receptor ligands |
| 02/27/2014 | WO2014030002A2 Molecularly imprinted polymers |
| 02/27/2014 | WO2014029832A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | WO2014029831A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | WO2014029830A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | WO2014029723A1 New bicyclicpyridine derivatives |
| 02/27/2014 | WO2014029722A1 Novel pyridine derivatives |
| 02/27/2014 | WO2014029684A1 Pesticidally active pyridyl- and pyrimidyl- substituted pyrazole derivatives |
| 02/27/2014 | WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals |
| 02/27/2014 | WO2014028968A1 Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof |
| 02/27/2014 | WO2013190137A3 Novel anti-cancer thiophene compounds |
| 02/27/2014 | US20140058100 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/27/2014 | US20140057952 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 02/27/2014 | US20140057949 Beverage Products |
| 02/27/2014 | US20140057942 Novel rock inhibitors |
| 02/27/2014 | US20140057927 Inhibitors of beta-secretase |
| 02/27/2014 | US20140057926 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | US20140057919 Fluoro-pyridinone derivatives useful as antibacterial agents |
| 02/27/2014 | US20140057916 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | US20140057915 Kinase inhibitors |
| 02/27/2014 | US20140057912 Pyrimidine-4,6-diamine derivatives as pi3k inhibitors |
| 02/27/2014 | US20140057911 Novel 4,6-disubstituted aminopyrimidine derivatives having both aromatic and halogenic substituents |
| 02/27/2014 | US20140057910 Heterocyclic aspartyl protease inhibitors |
| 02/27/2014 | US20140057909 Novel Indole Derivative or Pharmaceutically Acceptable Salt Thereof, Preparation Method Thereof, and Pharmaceutical Composition for Preventing or Treating Metabolic Diseases Containing Same as Active Ingredient |
| 02/27/2014 | US20140057893 Substituted cycloproply compounds, compositions containing such compounds and methods of treatment |
| 02/27/2014 | US20140057892 Prolyl hydroxylase inhibitors and methods of use |
| 02/27/2014 | US20140057891 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds |
| 02/27/2014 | US20140057890 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2014 | US20140057889 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2014 | US20140057882 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/26/2014 | EP2700653A2 Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use therefor |
| 02/26/2014 | EP2699563A1 Novel pesticidal pyrazole compounds |
| 02/26/2014 | EP2699562A1 Bicyclic heterocycle compounds and their uses in therapy |
| 02/26/2014 | EP2699561A1 Androgen receptor modulating carboxamides |
| 02/26/2014 | EP2699560A2 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof |
| 02/26/2014 | EP2699554A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines |
| 02/26/2014 | EP2699553A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| 02/26/2014 | EP2699551A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors |
| 02/26/2014 | EP2699550A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors |
| 02/26/2014 | EP2699547A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators |
| 02/26/2014 | CN103608342A Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids |
| 02/26/2014 | CN103608335A Pyrimidine derivatives for the treatment of viral infections |
| 02/26/2014 | CN103608333A 雄激素受体拮抗剂及其用途 Androgen receptor antagonists and their use |
| 02/26/2014 | CN103608332A Pyridin-2-amides useful as CB2 agonists |
| 02/26/2014 | CN103601722A Novel antineoplastic compounds |
| 02/26/2014 | CN103601719A 2, 2'-bipyridine-6, 6'-diformyl-quinolyl-2-amine derivative, and preparation method and applications thereof |
| 02/26/2014 | CN103601718A O-formammidotiazol-benzamide derivatives based on ryanodine receptor, and preparation method and applications thereof |
| 02/26/2014 | CN103601717A Novel preparation method of lenalidomide |
| 02/26/2014 | CN103601674A Compounds for inhibiting dipeptide kininase, preparation method and applications thereof |
| 02/26/2014 | CN103601670A Piplartine analogue, and preparation method and application thereof |
| 02/26/2014 | CN103054797B Pharmaceutical composition of pantoprazole sodium and preparation method thereof |
| 02/26/2014 | CN102725283B Compounds and compositions as protein kinase inhibitors |
| 02/26/2014 | CN102712620B 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 02/26/2014 | CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 02/26/2014 | CN102372692B 二氢吡啶衍生物 Dihydropyridine derivatives |
| 02/26/2014 | CN102099352B STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 02/26/2014 | CN102036961B Pyridines and pyrazines as inhibitors of PI3K |
| 02/26/2014 | CN101687802B Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 02/25/2014 | US8658801 Pesticides containing a bicyclic bisamide structure |
| 02/25/2014 | US8658800 Ortho-substituted arylamide derivatives |
| 02/25/2014 | US8658799 Process for the preparation of crystalline modifications for use in the preparation of esomeperazole sodium salt |
| 02/25/2014 | US8658798 Herbicide triazolylpyridine ketones |
| 02/25/2014 | US8658655 Inhibition of activated cdc42-associated kinase 1 |
| 02/25/2014 | US8658654 Receptor-type kinase modulators and methods of use |
| 02/25/2014 | US8658651 Compounds that are ERK inhibitors |
| 02/25/2014 | US8658639 N-substituted-cyclic amino derivative |
| 02/25/2014 | US8658636 TRPV4 antagonists |
| 02/25/2014 | US8658434 Fluorescent pyrene compounds |
| 02/25/2014 | CA2777632C Imidazole derivatives as casein kinase inhibitors |
| 02/25/2014 | CA2636993C Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 02/25/2014 | CA2630410C 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 02/22/2014 | CA2787472A1 Protein kinase inhibitors |
| 02/20/2014 | WO2014028801A1 Cyclopentylpyrazoles as n-type calcium channel blockers |
| 02/20/2014 | WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | WO2014028381A1 Apoptosis-inducing agents |
| 02/20/2014 | WO2014028322A1 Modulators of the histamine h3 receptor and the treatment of disorders related thereto |
| 02/20/2014 | WO2014027209A1 Pyrazolyl-ureas as kinase inhibitors |
| 02/20/2014 | WO2014027053A1 Benzimidazoles for the treatment of cancer |
| 02/20/2014 | WO2014026997A1 2,3-benzodiazepines |
| 02/20/2014 | WO2014026882A1 Azaheterocycles as bir2 and/or bir3 inhibitors |
| 02/20/2014 | WO2014026657A2 A process for the preparation of a derivative of 2-methyl-2'-phenylpropionic acid using new intermediates |
| 02/20/2014 | WO2014026467A1 Bicyclic substituted pyrimidine compounds |
| 02/20/2014 | WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| 02/20/2014 | WO2014026243A1 Vegfr3 inhibitors |
| 02/20/2014 | US20140051853 Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 02/20/2014 | US20140051852 Process for Synthesizing Oxidized Lactam Compounds |
| 02/20/2014 | US20140051729 Compositions and methods for treating degenerative muscle conditions |
| 02/20/2014 | US20140051728 Dabigatran in tumor therapy |
| 02/20/2014 | US20140051727 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
| 02/20/2014 | US20140051714 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |